Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate Cancer.

Curr Oncol · 2024 · PMC11430621 · PMID 39330003

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

nearing significancep = 0.057so close (0.05 < p ≤ 0.1)

Baseline ALP before FST, though nearing significance, was not associated with response ( p = 0.057).

also in 74 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.